Epic Sciences Launches Blood-Based Test for Metastatic Breast Cancer Patients
The novel metastatic breast cancer test includes both cell-based and cell-free analysis from a single blood draw.
Read MorePosted by Andy Lundin | Dec 17, 2021 | Breast, Hematology & Serology |
The novel metastatic breast cancer test includes both cell-based and cell-free analysis from a single blood draw.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Lymphoma, Molecular Diagnostics |
Genomic Testing Cooperative will present data on the use of their machine learning solution that reflects its innovation strategy in improving cancer care.
Read MorePosted by Andy Lundin | Nov 30, 2021 | Biochemicals & Chemical Reagents, Middleware & Software |
The solution is designed to help labs drive operational efficiencies across their supply chain by reducing reagent waste and limiting unnecessary costs.
Read MorePosted by Chris Wolski | Nov 26, 2021 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Researchers examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood.
Read More